Many patients need an ongoing framework that includes medical monitoring, behavior change, nutritional consistency, and periodic reassessment of goals
Appetite , 81 , 295304
Mechanisms of Action-Mediated DDIs Furthermore, assessing DDIs for GLP-1 RAs and a dual GLP-1/GIP RA requires additional considerations, including the possible occurrence of DDIs mediated by mechanisms of action that remain poorly understood (Figure 3)
519 While early models have shown promising results, the application of GLP-1RAs in cancer treatment has not yet been established and requires further clinical trials
Friedman AN, Kaplan LM, le Roux CW, Schauer PR
Liver Fat Reduction: Research indicates it can reduce hepatic fat by roughly 37%, which has sparked interest in its potential use against metabolic dysfunction-associated steatotic liver disease (MASLD)